{"id":139293,"date":"2022-05-13T08:02:34","date_gmt":"2022-05-13T13:02:34","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/05\/scientists-suggest-editing-human-genetic-code-to-prevent-heart-attacks"},"modified":"2022-05-13T08:02:34","modified_gmt":"2022-05-13T13:02:34","slug":"scientists-suggest-editing-human-genetic-code-to-prevent-heart-attacks","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/05\/scientists-suggest-editing-human-genetic-code-to-prevent-heart-attacks","title":{"rendered":"Scientists Suggest Editing Human Genetic Code to Prevent Heart Attacks"},"content":{"rendered":"

<\/a><\/p>\n

Heart attacks are the world\u2019s leading cause of death, yet the few treatments available are often expensive and inaccessible. Although that\u2019s been the case for years, the World Health Organization warned back in 2020<\/a> heart disease numbers were still on the rise.<\/p>\n

Verve Therapeutics says altering human genomes to prevent the buildup of bad cholesterol might be the answer, and is creating what CEO Sekar Kathiresan says may be a permanent solution to heart disease. The company is backed by Google Ventures, according to a report about the breakthrough published Friday in<\/a> Bloomberg<\/a>.<\/em> Verve also counts a Harvard medical professor and an award-winning medical expert<\/a> among its cofounders.<\/p>\n

\u201cWe\u2019re on the cusp of potentially transforming that model to a one-and-done treatment,\u201d Kathiresan told the business publication.<\/p>\n","protected":false},"excerpt":{"rendered":"

Heart attacks are the world\u2019s leading cause of death, yet the few treatments available are often expensive and inaccessible. Although that\u2019s been the case for years, the World Health Organization warned back in 2020 heart disease numbers were still on the rise. Verve Therapeutics says altering human genomes to prevent the buildup of bad cholesterol [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,412],"tags":[],"class_list":["post-139293","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/139293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=139293"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/139293\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=139293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=139293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=139293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}